Lemaitre Vascular (LMAT) Tops Q4 EPS by 1c

Lemaitre Vascular (NASDAQ: LMAT) reported Q4 EPS of $0.21, $0.01 better than the analyst estimate of $0.20. Revenue for the quarter came in at $26.15 million versus the consensus estimate of $26.23 million.

GUIDANCE:

Lemaitre Vascular sees Q1 2018 EPS of $0.19-$0.21. Lemaitre Vascular sees Q1 2018 revenue of $26-26.6 million.

Lemaitre Vascular sees FY 2018 EPS of $0.96-$1.00. Lemaitre Vascular sees FY 2018 revenue of $11.0-111.6 million.

For earnings history and earnings-related data on Lemaitre Vascular (LMAT) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• HeartCore Enterprises, Inc. (HTCR) Misses Q2 EPS by 185c
• Outlook Therapeutics (OTLK) Misses Q3 EPS by 9c